<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33311468</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>11</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Aberrant interaction of FUS with the U1 snRNA provides a molecular mechanism of FUS induced amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>6341</StartPage><MedlinePgn>6341</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">6341</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-20191-3</ELocationID><Abstract><AbstractText>Mutations in the RNA-binding protein Fused in Sarcoma (FUS) cause early-onset amyotrophic lateral sclerosis (ALS). However, a detailed understanding of central RNA targets of FUS and their implications for disease remain elusive. Here, we use a unique blend of crosslinking and immunoprecipitation (CLIP) and NMR spectroscopy to identify and characterise physiological and pathological RNA targets of FUS. We find that U1 snRNA is the primary RNA target of FUS via its interaction with stem-loop 3 and provide atomic details of this RNA-mediated mode of interaction with the U1 snRNP. Furthermore, we show that ALS-associated FUS aberrantly contacts U1 snRNA at the Sm site with its zinc finger and traps snRNP biogenesis intermediates in human and murine motor neurons. Altogether, we present molecular insights into a FUS toxic gain-of-function involving direct and aberrant RNA-binding and strengthen the link between two motor neuron diseases, ALS and spinal muscular atrophy (SMA).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jutzi</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8381-7830</Identifier><AffiliationInfo><Affiliation>United Kingdom Dementia Research Institute Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campagne</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0094-4760</Identifier><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biophysics, Department of Biology, ETH Z&#xfc;rich, CH-8093, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Ralf</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Computational and Systems Biology, Biozentrum, University of Basel, CH-4056, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reber</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>United Kingdom Dementia Research Institute Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mechtersheimer</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>United Kingdom Dementia Research Institute Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gypas</LastName><ForeName>Foivos</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7233-8794</Identifier><AffiliationInfo><Affiliation>Computational and Systems Biology, Biozentrum, University of Basel, CH-4056, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedrich Miescher Institute for Biomedical Research, CH-4058, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schweingruber</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4505-9068</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Martino</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Celgene Institute of Translational Research (CITRE), 41092, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Schroetter</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biophysics, Department of Biology, ETH Z&#xfc;rich, CH-8093, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loughlin</LastName><ForeName>Fionna E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biophysics, Department of Biology, ETH Z&#xfc;rich, CH-8093, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, 3800, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devoy</LastName><ForeName>Anny</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1293-0630</Identifier><AffiliationInfo><Affiliation>United Kingdom Dementia Research Institute Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedlund</LastName><ForeName>Eva</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6347-0075</Identifier><AffiliationInfo><Affiliation>Department of Neuroscience, Karolinska Institutet, 171 77, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zavolan</LastName><ForeName>Mihaela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8832-2041</Identifier><AffiliationInfo><Affiliation>Computational and Systems Biology, Biozentrum, University of Basel, CH-4056, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allain</LastName><ForeName>Fr&#xe9;d&#xe9;ric H-T</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Institute of Molecular Biology and Biophysics, Department of Biology, ETH Z&#xfc;rich, CH-8093, Z&#xfc;rich, Switzerland. allain@bc.biol.ethz.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruepp</LastName><ForeName>Marc-David</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0003-3264-9800</Identifier><AffiliationInfo><Affiliation>United Kingdom Dementia Research Institute Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, UK. marc-david.ruepp@kcl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599550">FUS protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000599551">FUS protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012342">RNA, Small Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017412">Ribonucleoprotein, U1 Small Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405483">U1 small nuclear RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054730" MajorTopicYN="N">Protein Interaction Domains and Motifs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012342" MajorTopicYN="N">RNA, Small Nuclear</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017412" MajorTopicYN="N">Ribonucleoprotein, U1 Small Nuclear</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33311468</ArticleId><ArticleId IdType="pmc">PMC7733473</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-20191-3</ArticleId><ArticleId IdType="pii">10.1038/s41467-020-20191-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gallo JM, et al. The role of RNA and RNA processing in neurodegeneration. J. Neurosci. 2005;25:10372&#x2013;10375. doi: 10.1523/JNEUROSCI.3453-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3453-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725807</ArticleId><ArticleId IdType="pubmed">16280575</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Neumann M. FET proteins in frontotemporal dementia and amyotrophic lateral sclerosis. Brain Res. 2012;1462:40&#x2013;43. doi: 10.1016/j.brainres.2011.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.12.010</ArticleId><ArticleId IdType="pubmed">22261247</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations. Acta Neuropathol. 2012;124:705&#x2013;716. doi: 10.1007/s00401-012-1020-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1020-6</ArticleId><ArticleId IdType="pubmed">22842875</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez-Calvet M, et al. Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS. Acta Neuropathol. 2016;131:587&#x2013;604. doi: 10.1007/s00401-016-1544-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1544-2</ArticleId><ArticleId IdType="pubmed">26895297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato M, et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell. 2012;149:753&#x2013;767. doi: 10.1016/j.cell.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC6347373</ArticleId><ArticleId IdType="pubmed">22579281</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin FE, et al. The solution structure of FUS bound to RNA reveals a bipartite mode of RNA recognition with both sequence and shape specificity. Mol. Cell. 2019;73:490&#x2013;504 e496. doi: 10.1016/j.molcel.2018.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.11.012</ArticleId><ArticleId IdType="pubmed">30581145</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D, et al. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackl W, Fischer U, Luhrmann R. A 69-kD protein that associates reversibly with the Sm core domain of several spliceosomal snRNP species. J. Cell Biol. 1994;124:261&#x2013;272. doi: 10.1083/jcb.124.3.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.124.3.261</ArticleId><ArticleId IdType="pmc">PMC2119936</ArticleId><ArticleId IdType="pubmed">8294511</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S, et al. Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants. EMBO J. 2016;35:1504&#x2013;1521. doi: 10.15252/embj.201593791.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593791</ArticleId><ArticleId IdType="pmc">PMC4946139</ArticleId><ArticleId IdType="pubmed">27252488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, et al. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012;15:1488&#x2013;1497. doi: 10.1038/nn.3230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3230</ArticleId><ArticleId IdType="pmc">PMC3586380</ArticleId><ArticleId IdType="pubmed">23023293</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiihashi G, et al. Mislocated FUS is sufficient for gain-of-toxic-function amyotrophic lateral sclerosis phenotypes in mice. Brain. 2016;139:2380&#x2013;2394. doi: 10.1093/brain/aww161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww161</ArticleId><ArticleId IdType="pubmed">27368346</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic, J. et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J.10.15252/embj.201592559 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoy A, et al. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in &#x2018;FUSDelta14&#x2019; knockin mice. Brain. 2017;140:2797&#x2013;2805. doi: 10.1093/brain/awx248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx248</ArticleId><ArticleId IdType="pmc">PMC5841203</ArticleId><ArticleId IdType="pubmed">29053787</ArticleId></ArticleIdList></Reference><Reference><Citation>Daigle JG, et al. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations. Hum. Mol. Genet. 2013;22:1193&#x2013;1205. doi: 10.1093/hmg/dds526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds526</ArticleId><ArticleId IdType="pmc">PMC3578413</ArticleId><ArticleId IdType="pubmed">23257289</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, et al. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ule J, Jensen K, Mele A, Darnell RB. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods. 2005;37:376&#x2013;386. doi: 10.1016/j.ymeth.2005.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2005.07.018</ArticleId><ArticleId IdType="pubmed">16314267</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutandy FXR, et al. In vitro iCLIP-based modeling uncovers how the splicing factor U2AF2 relies on regulation by cofactors. Genome Res. 2018;28:699&#x2013;713. doi: 10.1101/gr.229757.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.229757.117</ArticleId><ArticleId IdType="pmc">PMC5932610</ArticleId><ArticleId IdType="pubmed">29643205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee FCY, Ule J. Advances in CLIP technologies for studies of protein-RNA interactions. Mol. Cell. 2018;69:354&#x2013;369. doi: 10.1016/j.molcel.2018.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.01.005</ArticleId><ArticleId IdType="pubmed">29395060</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B, et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012;2:603. doi: 10.1038/srep00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00603</ArticleId><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber, S. et al. The phase separation-dependent FUS interactome reveals nuclear and cytoplasmic function of liquid-liquid phase separation. Preprint at https://www.biorxiv.org/content/10.1101/806158v1 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/806158v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Darnell RB. Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat. Biotechnol. 2011;29:607&#x2013;614. doi: 10.1038/nbt.1873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1873</ArticleId><ArticleId IdType="pmc">PMC3400429</ArticleId><ArticleId IdType="pubmed">21633356</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, et al. ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat. Commun. 2015;6:6171. doi: 10.1038/ncomms7171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7171</ArticleId><ArticleId IdType="pmc">PMC4338613</ArticleId><ArticleId IdType="pubmed">25625564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Reed R. FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP. Proc. Natl Acad. Sci. USA. 2015;112:8608&#x2013;8613. doi: 10.1073/pnas.1506282112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1506282112</ArticleId><ArticleId IdType="pmc">PMC4507187</ArticleId><ArticleId IdType="pubmed">26124092</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomeranz Krummel DA, Oubridge C, Leung AK, Li J, Nagai K. Crystal structure of human spliceosomal U1 snRNP at 5.5 A resolution. Nature. 2009;458:475&#x2013;480. doi: 10.1038/nature07851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07851</ArticleId><ArticleId IdType="pmc">PMC2673513</ArticleId><ArticleId IdType="pubmed">19325628</ArticleId></ArticleIdList></Reference><Reference><Citation>Charenton C, Wilkinson ME, Nagai K. Mechanism of 5&#x2019; splice site transfer for human spliceosome activation. Science. 2019;364:362&#x2013;367. doi: 10.1126/science.aax3289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax3289</ArticleId><ArticleId IdType="pmc">PMC6525098</ArticleId><ArticleId IdType="pubmed">30975767</ArticleId></ArticleIdList></Reference><Reference><Citation>Campagne S, et al. Structural basis of a small molecule targeting RNA for a specific splicing correction. Nat. Chem. Biol. 2019;15:1191&#x2013;1198. doi: 10.1038/s41589-019-0384-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-019-0384-5</ArticleId><ArticleId IdType="pubmed">31636429</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellizzoni L, Yong J, Dreyfuss G. Essential role for the SMN complex in the specificity of snRNP assembly. Science. 2002;298:1775&#x2013;1779. doi: 10.1126/science.1074962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1074962</ArticleId><ArticleId IdType="pubmed">12459587</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S, et al. CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells. Mol. Biol. Cell. 2018;29:75&#x2013;83. doi: 10.1091/mbc.E17-05-0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E17-05-0288</ArticleId><ArticleId IdType="pmc">PMC5909934</ArticleId><ArticleId IdType="pubmed">29167381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen J, Aguila J, Hoogstraaten R, Kee N, Hedlund E. Axon-Seq decodes the motor axon transcriptome and its modulation in response to ALS. Stem Cell Rep. 2018;11:1565&#x2013;1578. doi: 10.1016/j.stemcr.2018.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.11.005</ArticleId><ArticleId IdType="pmc">PMC6294264</ArticleId><ArticleId IdType="pubmed">30540963</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J, Reid D, Lau S, Kim Y, Gage FH. Aging in a dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases. Annu. Rev. Genet. 2018;52:271&#x2013;293. doi: 10.1146/annurev-genet-120417-031534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-120417-031534</ArticleId><ArticleId IdType="pmc">PMC6415910</ArticleId><ArticleId IdType="pubmed">30208291</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutten S, Chachami G, Winter U, Melchior F, Lamond AI. A role for the Cajal-body-associated SUMO isopeptidase USPL1 in snRNA transcription mediated by RNA polymerase II. J. Cell Sci. 2014;127:1065&#x2013;1078. doi: 10.1242/jcs.141788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.141788</ArticleId><ArticleId IdType="pmc">PMC3937775</ArticleId><ArticleId IdType="pubmed">24413172</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusty AB, et al. Impaired spliceosomal UsnRNP assembly leads to Sm mRNA down-regulation and Sm protein degradation. J. Cell Biol. 2017;216:2391&#x2013;2407. doi: 10.1083/jcb.201611108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201611108</ArticleId><ArticleId IdType="pmc">PMC5551706</ArticleId><ArticleId IdType="pubmed">28637748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahl MC, Will CL, Luhrmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136:701&#x2013;718. doi: 10.1016/j.cell.2009.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.009</ArticleId><ArticleId IdType="pubmed">19239890</ArticleId></ArticleIdList></Reference><Reference><Citation>Allain FH, Varani G. Divalent metal ion binding to a conserved wobble pair defining the upstream site of cleavage of group I self-splicing introns. Nucleic Acids Res. 1995;23:341&#x2013;350. doi: 10.1093/nar/23.3.341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/23.3.341</ArticleId><ArticleId IdType="pmc">PMC306681</ArticleId><ArticleId IdType="pubmed">7885828</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelly W, Fellows B, Senior K, Marlowe T, Sharma S. Identification of a noncanonical RNA binding domain in the U2 snRNP protein SF3A1. RNA. 2019;25:1509&#x2013;1521. doi: 10.1261/rna.072256.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.072256.119</ArticleId><ArticleId IdType="pmc">PMC6795144</ArticleId><ArticleId IdType="pubmed">31383795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S, Maris C, Allain FH, Black DL. U1 snRNA directly interacts with polypyrimidine tract-binding protein during splicing repression. Mol. Cell. 2011;41:579&#x2013;588. doi: 10.1016/j.molcel.2011.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2011.02.012</ArticleId><ArticleId IdType="pmc">PMC3931528</ArticleId><ArticleId IdType="pubmed">21362553</ArticleId></ArticleIdList></Reference><Reference><Citation>Arenas, A. et al. Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS. Hum. Mol. Genet. 10.1093/hmg/ddaa159 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530527</ArticleId><ArticleId IdType="pubmed">32691043</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda, A. et al. tRIP-seq reveals repression of premature polyadenylation by co-transcriptional FUS-U1 snRNP assembly. EMBO R. e49890, 10.15252/embr.201949890 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202220</ArticleId><ArticleId IdType="pubmed">32189459</ArticleId></ArticleIdList></Reference><Reference><Citation>Kino Y, et al. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations. Nucleic Acids Res. 2011;39:2781&#x2013;2798. doi: 10.1093/nar/gkq1162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq1162</ArticleId><ArticleId IdType="pmc">PMC3074126</ArticleId><ArticleId IdType="pubmed">21109527</ArticleId></ArticleIdList></Reference><Reference><Citation>Workman E, et al. A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice. Hum. Mol. Genet. 2009;18:2215&#x2013;2229. doi: 10.1093/hmg/ddp157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp157</ArticleId><ArticleId IdType="pmc">PMC2685758</ArticleId><ArticleId IdType="pubmed">19329542</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabanella F, et al. Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS ONE. 2007;2:e921. doi: 10.1371/journal.pone.0000921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000921</ArticleId><ArticleId IdType="pmc">PMC1976558</ArticleId><ArticleId IdType="pubmed">17895963</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler C, et al. Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes Dev. 2005;19:2320&#x2013;2330. doi: 10.1101/gad.342005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.342005</ArticleId><ArticleId IdType="pmc">PMC1240041</ArticleId><ArticleId IdType="pubmed">16204184</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy R, et al. Microcephalic osteodysplastic primordial dwarfism type I with biallelic mutations in the RNU4ATAC gene. Clin. Genet. 2012;82:140&#x2013;146. doi: 10.1111/j.1399-0004.2011.01756.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2011.01756.x</ArticleId><ArticleId IdType="pmc">PMC3816635</ArticleId><ArticleId IdType="pubmed">21815888</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsaid MF, et al. Mutation in noncoding RNA RNU12 causes early onset cerebellar ataxia. Ann. Neurol. 2017;81:68&#x2013;78. doi: 10.1002/ana.24826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24826</ArticleId><ArticleId IdType="pubmed">27863452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lardelli RM, et al. Biallelic mutations in the 3&#x2019; exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing. Nat. Genet. 2017;49:457&#x2013;464. doi: 10.1038/ng.3762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3762</ArticleId><ArticleId IdType="pmc">PMC5325768</ArticleId><ArticleId IdType="pubmed">28092684</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauw HM, et al. SMN1 gene duplications are associated with sporadic ALS. Neurology. 2012;78:776&#x2013;780. doi: 10.1212/WNL.0b013e318249f697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318249f697</ArticleId><ArticleId IdType="pmc">PMC3304946</ArticleId><ArticleId IdType="pubmed">22323753</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldink JH, et al. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology. 2005;65:820&#x2013;825. doi: 10.1212/01.wnl.0000174472.03292.dd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000174472.03292.dd</ArticleId><ArticleId IdType="pubmed">16093455</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, et al. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice. Neurobiol. Aging. 2014;35:906&#x2013;915. doi: 10.1016/j.neurobiolaging.2013.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.030</ArticleId><ArticleId IdType="pmc">PMC3919158</ArticleId><ArticleId IdType="pubmed">24210254</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen EJ, et al. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum. Mol. Genet. 2013;22:3690&#x2013;3704. doi: 10.1093/hmg/ddt222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt222</ArticleId><ArticleId IdType="pubmed">23681068</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T, et al. FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2012;2:799&#x2013;806. doi: 10.1016/j.celrep.2012.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.025</ArticleId><ArticleId IdType="pmc">PMC3483417</ArticleId><ArticleId IdType="pubmed">23022481</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi B, et al. The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex. Nucleic Acids Res. 2018;46:11939&#x2013;11951. doi: 10.1093/nar/gky1093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1093</ArticleId><ArticleId IdType="pmc">PMC6294556</ArticleId><ArticleId IdType="pubmed">30398641</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V, Carri MT, Cozzolino M, Achsel T. Mislocalised F. U. S. mutants stall spliceosomal snRNPs in the cytoplasm. Neurobiol. Dis. 2013;55:120&#x2013;128. doi: 10.1016/j.nbd.2013.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.03.003</ArticleId><ArticleId IdType="pubmed">23523636</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, et al. U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish. Nucleic Acids Res. 2015;43:3208&#x2013;3218. doi: 10.1093/nar/gkv157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv157</ArticleId><ArticleId IdType="pmc">PMC4381066</ArticleId><ArticleId IdType="pubmed">25735748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirra A, et al. Functional interaction between FUS and SMN underlies SMA-like splicing changes in wild-type hFUS mice. Sci. Rep. 2017;7:2033. doi: 10.1038/s41598-017-02195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-02195-0</ArticleId><ArticleId IdType="pmc">PMC5435706</ArticleId><ArticleId IdType="pubmed">28515487</ArticleId></ArticleIdList></Reference><Reference><Citation>Saltzman AL, Pan Q, Blencowe BJ. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev. 2011;25:373&#x2013;384. doi: 10.1101/gad.2004811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.2004811</ArticleId><ArticleId IdType="pmc">PMC3042160</ArticleId><ArticleId IdType="pubmed">21325135</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Erauskin J, et al. ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron. 2018;100:816&#x2013;830 e817. doi: 10.1016/j.neuron.2018.09.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pmc">PMC6277851</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S, et al. Evidence that C9ORF72 dipeptide repeat proteins associate with U2 snRNP to cause mis-splicing in ALS/FTD patients. Cell Rep. 2017;19:2244&#x2013;2256. doi: 10.1016/j.celrep.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuiji H, et al. Spliceosome integrity is defective in the motor neuron diseases ALS and SMA. EMBO Mol. Med. 2013;5:221&#x2013;234. doi: 10.1002/emmm.201202303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201202303</ArticleId><ArticleId IdType="pmc">PMC3569639</ArticleId><ArticleId IdType="pubmed">23255347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara T, et al. Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22:4136&#x2013;4147. doi: 10.1093/hmg/ddt262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt262</ArticleId><ArticleId IdType="pubmed">23740936</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaida D, et al. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature. 2010;468:664&#x2013;668. doi: 10.1038/nature09479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09479</ArticleId><ArticleId IdType="pmc">PMC2996489</ArticleId><ArticleId IdType="pubmed">20881964</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller, R. The Computer-aided Resonance Assignment Tutorial (Cantina Verlag, 2004).</Citation></Reference><Reference><Citation>Herrmann T, Guntert P, Wuthrich K. Protein NMR structure determination with automated NOE-identification in the NOESY spectra using the new software ATNOS. J. Biomol. NMR. 2002;24:171&#x2013;189. doi: 10.1023/A:1021614115432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1021614115432</ArticleId><ArticleId IdType="pubmed">12522306</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntert P, Buchner L. Combined automated NOE assignment and structure calculation with CYANA. J. Biomol. NMR. 2015;62:453&#x2013;471. doi: 10.1007/s10858-015-9924-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10858-015-9924-9</ArticleId><ArticleId IdType="pubmed">25801209</ArticleId></ArticleIdList></Reference><Reference><Citation>Case DA, et al. The Amber biomolecular simulation programs. J. Comput Chem. 2005;26:1668&#x2013;1688. doi: 10.1002/jcc.20290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20290</ArticleId><ArticleId IdType="pmc">PMC1989667</ArticleId><ArticleId IdType="pubmed">16200636</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey, J. et al. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res.10.1093/nar/gkaa410 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337901</ArticleId><ArticleId IdType="pubmed">32479602</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Flemr M, Buhler M. Single-step generation of conditional knockout mouse embryonic stem cells. Cell Rep. 2015;12:709&#x2013;716. doi: 10.1016/j.celrep.2015.06.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.06.051</ArticleId><ArticleId IdType="pubmed">26190102</ArticleId></ArticleIdList></Reference><Reference><Citation>Maury Y, et al. Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 2015;33:89&#x2013;96. doi: 10.1038/nbt.3049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3049</ArticleId><ArticleId IdType="pubmed">25383599</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 2017;8:861. doi: 10.1038/s41467-017-00911-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 2011;17:10&#x2013;12. doi: 10.14806/ej.17.1.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.14806/ej.17.1.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078&#x2013;2079. doi: 10.1093/bioinformatics/btp352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz R, et al. ViennaRNA package 2.0. Algorithms Mol. Biol. 2011;6:26. doi: 10.1186/1748-7188-6-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-7188-6-26</ArticleId><ArticleId IdType="pmc">PMC3319429</ArticleId><ArticleId IdType="pubmed">22115189</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey TL, et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res. 2009;37:W202&#x2013;W208. doi: 10.1093/nar/gkp335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp335</ArticleId><ArticleId IdType="pmc">PMC2703892</ArticleId><ArticleId IdType="pubmed">19458158</ArticleId></ArticleIdList></Reference><Reference><Citation>Koster J, Rahmann S. Snakemake&#x2013;a scalable bioinformatics workflow engine. Bioinformatics. 2012;28:2520&#x2013;2522. doi: 10.1093/bioinformatics/bts480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts480</ArticleId><ArticleId IdType="pubmed">22908215</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>